-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS INC : LEERINK PARTNERS CUTS TARGET PRICE TO $351 FROM $370

Reuters·12/15/2025 11:57:44

Please log in to view news